Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis.
Feb 4, 2026DOI: 10.1093/cid/ciaf286Journal ArticleCID
Written by: Chen WangBrenna A LaBereMichell M Lozano ChingaAnnalie J HarrisLindsey B RosenAmanda Elias RiveraEva Le RunKeith A SaccoWassim BallanJames V WoodwardScott A OstdiekMatthew W SmithVictoria L AndersonJanine R DaubCindy L PalmerLavenda Chirombo KluczynskiAndrew J OlerMagdalena A WalkiewiczRajarshi GhoshMorgan SimilukFariba M DonovanJohn WittNicolas BarrosL Joseph WheatJohn N GalgianiAlexandra F FreemanAmy P HsuChrista S ZerbeSteven M Holland
Refractory disseminated coccidioidomycosis (DCM) is a severe disease with limited treatment options. This report reviews our own and prior published experiences using adjunctive interferon-γ therapy in refractory DCM, showing overall favorable responses in patients without signal transducer and activator of transcription 1 gain-of-function mutations.
JG
Dr. John Galgiani
Infectious Disease · General Infectious DiseaseUniversity of Arizona College of Medicine- Phoenixjohngalgiani